Comment
[Commentary to the article: Swedberg K, Komajda M, Böhm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet, 2010; DOI:10.1016/S01406736(10)61198-1]
[Article in
Polish]
- PMID: 21108219
Item in Clipboard
Comment
[Commentary to the article: Swedberg K, Komajda M, Böhm M et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet, 2010; DOI:10.1016/S01406736(10)61198-1]
[Article in
Polish]
Kardiol Pol.
2010 Nov.
No abstract available
Comment on
-
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Lancet. 2010. PMID: 20801500 Clinical Trial.
Similar articles
-
RETRACTED: Ivabradine as adjuvant treatment for chronic heart failure.Int J Cardiol. 2017 Jan 15;227:43-50. doi: 10.1016/j.ijcard.2016.11.081. Epub 2016 Nov 9. Int J Cardiol. 2017. PMID: 27846461 Retracted.
-
[Commentary to the article: Kedhi E, Joesoef KS, McFadden E et al. Second-generation everolimus- -eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet, 2010; 375: 201-209].Kardiol Pol. 2010 Apr;68(4):493-6; discussion 497-9. Kardiol Pol. 2010. PMID: 20425722 Polish. No abstract available.
-
[Commentary to the article: Di Mario C, Dudek D, Piscione F, et al.; CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet 2008; 371: 559-68].Kardiol Pol. 2008 Apr;66(4):461-4; discussion 465-6. Kardiol Pol. 2008. PMID: 18634182 Polish. No abstract available.
-
Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.Am J Cardiovasc Drugs. 2009;9 Suppl 1:9-12. doi: 10.2165/1153162-S0-000000000-00000. Am J Cardiovasc Drugs. 2009. PMID: 20000882 Review.
-
Rate control with ivabradine: angina pectoris and beyond.Am J Cardiovasc Drugs. 2011;11(1):1-12. doi: 10.2165/11584840-000000000-00000. Am J Cardiovasc Drugs. 2011. PMID: 21090826 Review.
Cited by
-
Association Between Cystatin C and Cardiac Function and Long-Term Prognosis in Patients with Chronic Heart Failure.Med Sci Monit. 2020 Feb 16;26:e919422. doi: 10.12659/MSM.919422. Med Sci Monit. 2020. PMID: 32062670 Free PMC article.
-
Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study.Clin Res Cardiol. 2012 Feb;101(2):139-47. doi: 10.1007/s00392-011-0375-3. Epub 2011 Nov 3. Clin Res Cardiol. 2012. PMID: 22048696
-
Heart rate reduction in cardiovascular disease and therapy.Clin Res Cardiol. 2011 Jan;100(1):11-9. doi: 10.1007/s00392-010-0207-x. Epub 2010 Sep 1. Clin Res Cardiol. 2011. PMID: 20809390 Review.